MESA, Ariz., Nov. 22, 2011 /PRNewswire/ -- Matthew Likens, president and CEO of Ulthera, Inc. – a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology – is scheduled to present at two upcoming healthcare conferences:
-- Tuesday, Nov. 29 at 2:10 p.m. EST |
23rd Annual Piper Jaffray Healthcare Conference in New York City, Nov. 29-30, 2011 |
Location: The New York Palace Hotel, 455 Madison Avenue, New York 10022 |
|
-- Tuesday, Dec. 6 at 12:00 p.m. PT |
6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference in San Francisco, Dec. 6, 2011 |
Location: St. Regis, 125 3rd Street, San Francisco 94103 |
Likens will present an overview of the company as well as its accomplishments to date and prospects for the future.
(Logo: http://photos.prnewswire.com/prnh/20111122/NY10856LOGO )
About Ulthera
Ulthera®, Inc. is a global, commercial-stage medical device company pioneering aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive FDA clearance for a non-invasive aesthetic lift indication. The first application for Ultherapy® – the procedure enabled by the System – is a non-invasive face and neck treatment to achieve a brow lift. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top tier venture capital firms, New Enterprise Associates and Apposite Capital. For more information, visit www.ulthera.com.
SOURCE Ulthera, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article